Can changes in angiogenic biomarkers between the first and second trimesters of pregnancy predict development of pre-eclampsia in a low-risk nulliparous patient population?-Reference-Cited by-同舟云学术

Can changes in angiogenic biomarkers between the first and second trimesters of pregnancy predict development of pre-eclampsia in a low-risk nulliparous patient population?

Published:2013-01-18 Issue:10 Volume:120 Page:1183-1191
ISSN:1470-0328
Container-title:BJOG: An International Journal of Obstetrics & Gynaecology
language:en
Short-container-title:BJOG

Author:

Myatt L¹,Clifton RG²,Roberts JM³,Spong CY⁴,Wapner RJ⁵,Thorp JM⁶,Mercer BM⁷,Peaceman AM⁸,Ramin SM⁹,Carpenter MW¹⁰,Sciscione A¹¹,Tolosa JE¹²,Saade G¹³,Sorokin Y¹⁴,Anderson GD¹³,

Affiliation:

1. Department ofObstetrics and Gynecology; University of Cincinnati; Cincinnati OH USA

2. The George Washington University Biostatistics Center; Washington DC USA

3. Obstetrics, Gynecology and Reproductive Science; University of Pittsburgh; Pittsburgh PA USA

4. The Eunice Kennedy Shriver National Institute of Child Health and Human Development; Bethesda MD USA

5. Obstetrics and Gynecology; Columbia University; New York NY USA

6. Obstetrics and Gynecology; University of North Carolina at Chapel Hill; Chapel Hill NC USA

7. Maternal Fetal Medicine; Case Western Reserve University-MetroHealth Medical Center; Cleveland OH USA

8. Obstetrics and Gynecology; Northwestern University; Chicago IL USA

9. Obstetrics, Gynecology and Reproductive Science; University of Texas Health Science Center at Houston; Houston TX USA

10. Obstetrics and Gynecology; Brown University; Providence RI USA

11. Obstetrics and Gynecology; Christiana Care Health System; Newark DE USA

12. Obstetrics and Gynecology; Oregon Health & Science University; Portland OR USA

13. Obstetrics and Gynecology; University of Texas Medical Branch; Galveston TX USA

14. Obstetrics and Gynecology; Wayne State University; Detroit MI USA

Funder

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

National Heart, Lung, and Blood Institute

National Center for Research Resources

Publisher

Wiley

Subject

Obstetrics and Gynaecology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/1471-0528.12128/fullpdf

Reference21 articles.

1. Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Eclampsia Trial;Lancet,1995

2. The two stage model of preeclampsia: variations on the theme;Roberts;Placenta,2009

3. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia;Levine;N Engl J Med,2006

4. A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate;Romero;J Matern Fetal Neonatal Med,2008

Cited by 80 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the Spectrum of Electrolyte Imbalances in Preeclampsia: Mechanisms, Implications, and Clinical Insights;Cureus;2024-08-24

2. Maternal serum PlGF associates with 3D power doppler ultrasound markers of utero-placental vascular development in the first trimester: the rotterdam periconception cohort;Angiogenesis;2024-08-14

3. Maternal angiogenic factor disruptions prior to clinical diagnosis of preeclampsia: insights from the REVAMP study;Hypertension Research;2024-07-04

4. Differences in Cardiometabolic Proteins in Pregnancy Prioritize Relevant Targets of Preeclampsia;Arteriosclerosis, Thrombosis, and Vascular Biology;2024-04

5. Preeclampsia at term can be classified into 2 clusters with different clinical characteristics and outcomes based on angiogenic biomarkers in maternal blood;American Journal of Obstetrics and Gynecology;2023-05